date,title,source
Nov-27-18,"The Daily Biotech Pulse: Abeona Fires CEO, Loxo Passes FDA Muster, Bristol-Myers Flunks Lung Cancer Trial",Benzinga
Feb-04-19,Oncolytics Biotech(R) to Present at the 21st Annual BIO CEO & Investor Conference,ACCESSWIRE
Feb-11-19,Oncolytics Biotech(R) Announces Spanish Regulatory Approval of AWARE-1 Window of Opportunity Study in Breast Cancer,ACCESSWIRE
Feb-27-19,Oncolytics Biotech(R) Presents Biomarker Data in Second-line Pancreatic Cancer at AACR,ACCESSWIRE
Feb-28-19,Penny Stocks to Buy Using Technical Analysis for March 2019,Investopedia
Mar-01-19,Oncolytics Biotech(R) to Host Conference Call to Discuss Year End Financial Results and Operational Highlights,ACCESSWIRE
Mar-08-19,Oncolytics Biotech (R) Announces 2018 Year-End Results and Operational Highlights,ACCESSWIRE
Mar-28-19,Oncolytics Biotech (R) Announces a Publication Highlighting Synergistic Effect of Pelareorep with a Proteasome Inhibitor in Preclinical Models of Multiple Myeloma,ACCESSWIRE
Apr-02-19,Oncolytics Biotech (R) Presents Positive Clinical Biomarker Data at the American Association for Cancer Research Annual Meeting 2019,ACCESSWIRE
Apr-03-19,Oncolytics Biotech(R) to Present at the 18th Annual Needham Healthcare Conference,ACCESSWIRE
Apr-04-19,Oncolytics Biotech(R) to Host Key Opinion Leader Meeting on the Emerging Role of Biomarkers and Oncolytic Viruses in the Treatment of Cancer,ACCESSWIRE
Apr-08-19,Oncolytics Biotech(R) Announces First Patient Treated in Company's AWARE-1 Window of Opportunity Study of Pelareorep in Breast Cancer,ACCESSWIRE
Apr-23-19,Oncolytics Biotech(R) to Present at the 2019 Bloom Burton & Co. Healthcare Investor Conference,ACCESSWIRE
Apr-25-19,Oncolytics Biotech(R) Announces Details of 2019 Annual General Meeting of Shareholders,ACCESSWIRE
